About The Geneva Foundation
The Geneva Foundation is a 501(c)3 nonprofit established in 1993 with the purpose to ensure optimal health for service members and the communities they serve. This purpose is accomplished through our mission to advance military medicine through research, development, and education. Our vision is to lead the way in transforming military medicine. Our culture is living our core values that focus on a higher purpose. Geneva serves a diverse population and is committed to making diversity, equity, inclusion and belonging a central focus of the employee experience. As a leader in military medical research, we develop critical lifesaving solutions for the global community – and build rewarding careers for our employees.
Our benefits package includes financial rewards that are a significant part of the employee's total rewards compensation package. Geneva's highly competitive benefits include medical, dental, and vision healthcare, Flexible Spending Account, Health Savings account, with employer contribution. Coverage is provided for employees and family members including domestic partners. Short-and long-term disability, Employee Assistance Program, Life & ADD insurance, 403b retirement plan with generous employer match, flexible leave options, 11 paid holidays per year, and up to 4 weeks of paid time off in a rolling year. Employees may qualify for PSLF as Geneva is a 501(c)(3) nonprofit organization. Full time positions come with all benefits. Part time and intermittent positions may vary.
About The Position
The Postdoctoral Fellow I provides assistance to the Principal Investigator, Co-Investigators, and Research Staff. S/he ensures enrollment numbers are successfully met, when applicable, and protocol adherence, monitoring visits, overseeing regulatory and administrative details, data management assistance and project close-out support is provided. Responsibilities will include the production and design of monoclonal antibodies, conducting assays, developing ideas and concepts, and generating progress reports
This is an on-site position assigned to the Walter Reed Army Institute of Research, located in Silver Spring, MD. A thorough government background check will be required.
About The Project
The project will first optimize the duration for which mAb 317 can circulate in the blood. This will be done by changing the sequence of the monoclonal antibody, such that it binds better to cell receptors that prevent antibody destruction. We will test if combinations of mAb 317 with TMV-NPNAx5 vaccine can confer immediate protection in mice and give one more dose of the vaccine to allow the boosting of antibodies and make the protection last for up to 4 months in the mouse model. If we find that the monoclonal antibody with the vaccine can work together in tandem, then this will be a novel concept in malaria, similar to what is used for Rabies. Rabies exposure is routinely treated with a combination of immunoglobulins and a vaccine. The last two aims in this proposal will test if the mouse data holds up in higher primates (rhesus monkeys) and we will finally take step that will enable the manufacturing of a batch of the monoclonal antibody component. This grant encompasses the first steps to translate a novel combination prophylaxis against malaria towards development of a drug product for clinical trials in humans.
$78,660 - $95,000. Salaries are determined based on several factors including external market data, internal equity, and the candidate’s related knowledge, skills, and abilities for the position.